Core Points - Healthcare Triangle, Inc. (HCTI) has entered into warrant exercise agreements with accredited and institutional investors to exercise existing warrants for a total of 239,051 shares of common stock, generating approximately $478,000 in gross cash proceeds [1][2] - The existing warrants' exercise price has been reduced from $20.92 to $2.00 per share, and the new warrants will have an exercise price of $3.00 per share, with a five-year expiration from the date of issuance [1][2] Financial Details - The gross proceeds from the warrant inducement are expected to be around $478,000, excluding any potential proceeds from the exercise of the new warrants and before deducting financial advisor fees and other expenses [2] - The closing of the offering is anticipated to occur on or about October 8, 2025, subject to customary closing conditions [2]

Core Insights - WallachBeth Capital LLC announced that Healthcare Triangle, Inc. has entered into warrant exercise agreements with accredited and institutional investors [1] Company Summary - Healthcare Triangle, Inc. is recognized as a leader in digital transformation solutions for the healthcare and life sciences sectors [1] - The company has agreed to exercise outstanding warrants to purchase a total of 377,702 shares of its common stock [1]

Core Insights - Healthcare Triangle, Inc. has entered into warrant exercise agreements with three accredited investors to exercise existing warrants for a total of 812,775 shares of common stock, generating approximately $1.63 million in gross cash proceeds [1][2] - The existing warrants' exercise price has been reduced from $20.92 to $2.00 per share, and the new warrants will have an exercise price of $3.00 per share, with a total of 812,775 shares available for purchase [1] - The transaction is expected to close on October 2, 2025, subject to customary closing conditions [2] Financial Details - The gross proceeds from the warrant inducement are expected to be around $1.63 million, excluding potential proceeds from the exercise of the new warrants and before deducting placement agent fees and other expenses [2] - The new warrants will be exercisable upon stockholder approval and will expire five years from the date of such approval [1] Company Background - WallachBeth Capital LLC is acting as the sole placement agent for this warrant inducement transaction, providing capital markets and institutional execution services [2][4]